HealthCor Catalio Acquisition Corp. (NASDAQ: HCAQ), a special purpose acquisition company, in its $580 million combination with Hyperfine, Inc., creator of the first U.S. Food and Drug Administration cleared portable magnetic resonance imaging device, Swoop™, and Liminal Sciences, Inc., a medical device development company dedicated to non-invasive measurement of key vital signs in the brain.
Software Acquisition Group Inc. II (NASDAQ: SAII), a U.S. publicly-traded special purpose acquisition company, on its proposed merger with Otonomo Technologies Ltd.
HealthCor Catalio Acquisition Corp. (NASDAQ: HCAQ), a special purpose acquisition company, in its upsized IPO of 18,000,000 shares and the sale of an additional 2,700,000 shares in connection with the underwriter's full exercise of its over-allotment option. Affiliates of HealthCor Management, L.P. and Catalio Capital Management, LP sponsored the SPAC, which will target business acquisitions in the healthcare industry, including the biotechnology, pharmaceuticals, services and medical technology sub-sectors.
Atlas Technical Consultants, Inc. (NASDAQ: ATCX) on its consent solicitation and tender offer to exchange all outstanding warrants for shares of Class A common stock.
Jaws Acquisition Corp. (NYSE: JWS), a special purpose acquisition company sponsored by Barry Sternlicht and Joseph Dowling, on its proposed merger with Cano Health, LLC, including an $800 million concurrent private placement (PIPE) of common stock of the combined company.
